Announcements Trials
Browse Landscape

Phase

Phase 1 17Phase 2 14Phase 4 11Phase 3 8Phase NA 5Phase 1/2 5Phase EARLY_PHASE1 4Phase 2/3 2

Status

Unknown 3Withdrawn 1Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 4Dermatologic 1

Conditions

Uterine Cervical Dysplasia 3Vulvar Neoplasms 1Keratosis, Actinic 1

Interventions

Exercise 419Blood Specimen Collection 319Standard of Care 299Surveys and Questionnaires 242Radiosurgery 239Magnetic Resonance Spectroscopy 232Educational Status 223Methods 221Radiotherapy 216Early Intervention, Educational 200Interviews as Topic 142Practice Guidelines as Topic 141Biopsy 125Surgical Procedures, Operative 119Drug Therapy 119Acupuncture Therapy 119Control Groups 115Therapeutics 101Palliative Care 97Resistance Training 94Counseling 88Saline Solution 87Magnetic Resonance Imaging 84Cyclophosphamide 83Specimen Handling 73Cisplatin 73Radiofrequency Ablation 71Cognitive Behavioral Therapy 71Radiotherapy, Intensity-Modulated 68Colonoscopy 65

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase NA × OTHER × Imiquimod × Clear all
NCT04859361 2021-05-03

Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ

University Medical Centre Maribor

Phase NA Unknown
104 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT00814528 2018-09-10

Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses

University of Chicago

Phase NA Withdrawn
Dermatologic

Keratosis, Actinic

NCT02917746 2018-08-16

TOPIC-3

Maastricht University Medical Center

Phase NA Unknown
120 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT00504023 2018-06-06

Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva

Memorial Sloan Kettering Cancer Center

Phase NA Completed
8 enrolled 7 charts
Gynecologic

Vulvar Neoplasms

NCT03206138 2017-07-02

Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.

Seoul St. Mary's Hospital

Phase NA Unknown
50 enrolled
Gynecologic

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡